RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations.

Slides:

Advertisements

Similar presentations

Figure 4. Reduced Ab production in Egr1-/- mice

Advertisements

Shigella-specific serum IgG and IgA endpoint titers in guinea pigs immunized intranasally with S. flexneri 2a InvaplexNAT or InvaplexAR. Shigella-specific.

Serum IgG (A–D) and IgA (E–H) titer from BALB/c mice (n = 5/group) at day 0 or following COBRA P1 virus i.n., i.p., or i.m. prime at day 21 or following.

FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)

HA-specific Abs in serum 14 d after a single vaccination with the various targeted DNA vaccines. HA-specific Abs in serum 14 d after a single vaccination.

A single DNA vaccination of C57BL/6 mice induced Ab responses of IgG1 and/or IgG2c subclass. A single DNA vaccination of C57BL/6 mice induced Ab responses.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Protection from influenza virus challenge.

FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.

Identification of novel IgGs in alpaca serum.

Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

CXCR5+/+ TFH cells are dispensable for maintenance of the LCMV-specific antibody response. CXCR5+/+ TFH cells are dispensable for maintenance of the LCMV-specific.

Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.

Survival of BALB/c mice after HK/Syd challenge.

Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.

STAT3 regulates IgE class switching in a Th2-type response.

Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.

Survival and time to death of NZW rabbits following vaccination with AVA and subsequent lethal B. anthracis spore challenge (rabbit preexposure prophylaxis.

Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.

Immune response to vaccination with AVA in NZW rabbits (rabbit preexposure prophylaxis study). Immune response to vaccination with AVA in NZW rabbits (rabbit.

Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.

Survival and time to death of cynomolgus macaques following vaccination with AVA and subsequent lethal B. anthracis spore challenge (NHP preexposure prophylaxis.

Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.

Increased proinflammatory cytokine production is dependent on both the training interval and the resting time. Increased proinflammatory cytokine production.

NKTfh cell–driven class switch against polysaccharide Ag is IL-21-influenced. NKTfh cell–driven class switch against polysaccharide Ag is IL-21-influenced.

Contribution of individual serovars within serogroups isolated in the United States in Contribution of individual serovars within serogroups isolated.

Pulmonary vaccination induces a long-term immune memory response to antigen challenge. Pulmonary vaccination induces a long-term immune memory response.

Immune response to vaccination with AVA in cynomolgus macaques (NHP preexposure prophylaxis study). Immune response to vaccination with AVA in cynomolgus.

Reproducibility of LPA results for cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of LPA results for cryopreserved.

OVA-specific and InvaplexNAT-specific serum IgG endpoint titers in mice after intranasal immunization with OVA alone or OVA combined with InvaplexAR, InvaplexNAT,

Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02% to 2% (vol/vol) oil, as measured.

Anti-DNA Abs were not affected by the deletion of GCs in pristane-induced lupus model. Anti-DNA Abs were not affected by the deletion of GCs in pristane-induced.

Trained immunity induction of glycolysis.

T. gondii-specific IgG antibodies in 32 pregnant women treated with spiramycin from the time of diagnosis until delivery and in 16 nonpregnant patients.

Antibody titers against surface antigens of B

Trained immunity effects on cell morphology and numbers.

Results from human serum samples determined using the five-antigen multiplex assay. Results from human serum samples determined using the five-antigen.

IL-6 production with increasing doses of endotoxin.

RTA pepscan analysis of sera from RiVax- and RVEc-immunized mice.

Immunization regimens that include a GLA-SE-formulated protein vaccine generate memory CD4 T cells. Immunization regimens that include a GLA-SE-formulated.

Scattergrams showing IgG- and IgA-specific OD490 values measured with the Campylobacter-specific P18/P39 ELISA in sera from healthy controls and from GBS.

Fig. 6 Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles. Multivalent DNA vaccine and protein antigen delivery by T4-AAV nanoparticles.

Dilution of anti-C6 monoclonal antibody shows the broader linear range of the Multiplex assay in comparison to standard ELISA. Shown is the dilution of.

Reproducibility of CD4+ and CD8+ T-cell enumeration with cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of CD4+

Antibody titers against surface antigens of M

Relation between the total white blood count and the absolute lymphocyte count prior to the first vaccination and the response to vaccination. Relation.

Identification of the recombinant structural proteins expressed in recombinant baculovirus-infected Sf9 cells by immunofluorescence assay with rabbit anti-FMDV.

B- and T-cell activity induced by immunization.

DTH responses to multiple components of the ID93 fusion protein.

Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),

TNA associated with FD3-specific Abs.

Group-averaged IL-10 levels (in pg/ml) from the Luminex assay for control, CFS with FM, and CFS without FM groups. Group-averaged IL-10 levels (in pg/ml)

Diethylamine-based measles avidity assay.

Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.02%

Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5%

Time to culling for mastitis among J5 vaccinates and controls

Moderate-affinity vaccine antigens elicited greatest antitumor response. Moderate-affinity vaccine antigens elicited greatest antitumor response. Wild-type.

Antigen-specific cytokine production detected by multiplex bead assay (Luminex) 3 weeks after the 3rd immunization. Antigen-specific cytokine production.

Antigen-specific cytokine-producing cells (IFN-γ and IL-5) detected by ELISPOT assay 3 weeks after the 3rd immunization. Antigen-specific cytokine-producing.

Anti-PT IgG results from 227 patients with coughs of unknown etiology who reported the severity of cough on a scale from 0 to 10. Anti-PT IgG results from.

Comparison of quantitative results obtained with the Enzygnost antiVZV/IgG, Serion ELISA Classic VZV IgG, and Euroimmun anti-VZV ELISA (IgG) tests for.

Lkt antibody titers of vaccinated and control groups of BHS

Schematic presentation of the major domains of Alps, the signal peptide (S), the N-terminal region (N), the repeat region (R), and the C-terminal region.

Time to culling for all reasons among J5 vaccinates and controls

IgA and IgG antibodies reactive to TT, alpha-toxin, and BSA in two groups of chickens 2 weeks after oral gavage with probiotics or with PBS. The two groups.

Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.

Mean reciprocal IFA titer results for serum samples from experimentally vaccinated animals. Mean reciprocal IFA titer results for serum samples from experimentally.

Lack of innate immune cell and receptor triggering by Adjuplex.

Variability between laboratories in titer estimations (expressed as GCV on the y axis) tends to be higher for samples in low measurement ranges and to.

Presentation transcript:

RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations with indicated doses (10, 3, or 1 μg) of Alhydrogel-adsorbed RiVax or RVEc. (C) Prechallenge TNA EC50s in sera collected after three immunizations with RiVax or RVEc, as shown in panel B. (D) RTA-specific serum IgG GMTs after two immunizations with 0.3 μg of Alhydrogel-adsorbed RiVax or RVEc. An unpaired t test was used to compare the differences in serum IgG GMTs or TNA elicited by the same doses of RiVax and RVEc. *, P < 0.05, and ***, P < 0.001. RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations with indicated doses (10, 3, or 1 μg) of Alhydrogel-adsorbed RiVax or RVEc. (C) Prechallenge TNA EC50s in sera collected after three immunizations with RiVax or RVEc, as shown in panel B. (D) RTA-specific serum IgG GMTs after two immunizations with 0.3 μg of Alhydrogel-adsorbed RiVax or RVEc. An unpaired t test was used to compare the differences in serum IgG GMTs or TNA elicited by the same doses of RiVax and RVEc. *, P < 0.05, and ***, P < 0.001. Joanne M. O'Hara et al. Clin. Vaccine Immunol. 2013; doi:10.1128/CVI.00098-13